Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

BACKGROUND: We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after primary surgery for early breast cancer. Here, we pre...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lancet
Autori principali: Murray Brunt, Adrian, Haviland, Joanne S, Wheatley, Duncan A, Sydenham, Mark A, Alhasso, Abdulla, Bloomfield, David J, Chan, Charlie, Churn, Mark, Cleator, Susan, Coles, Charlotte E, Goodman, Andrew, Harnett, Adrian, Hopwood, Penelope, Kirby, Anna M, Kirwan, Cliona C, Morris, Carolyn, Nabi, Zohal, Sawyer, Elinor, Somaiah, Navita, Stones, Liba, Syndikus, Isabel, Bliss, Judith M, Yarnold, John R
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Author(s). Published by Elsevier Ltd. 2020
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262592/
https://ncbi.nlm.nih.gov/pubmed/32580883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(20)30932-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi